The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1
Open accessAbstract
The present study was performed to investigate the ability of the multidrug resistance protein (MRP1) to transport different cationic substrates in comparison with MDR1‐P‐glycoprotein (MDR1). Transport studies were performed with isolated membrane vesicles from in vitro selected multidrug resistant cell lines overexpressing MDR1 (A2780AD) or MRP1 (GLC 4/Adr) and a MRP1‐transfected cell line (S1(MRP)). As substrates we used 3 H‐labelled derivatives of the hydrophilic monoquaternary cation N‐(4′,4′‐azo‐n‐pentyl)‐21‐deoxy‐ajmalinium (APDA), the basic drug vincristine and the more hydrophobic basic drug daunorubicin. All three are known MDR1‐substrates. MRP1 did not mediate transport of these substrates per se. In the presence of reduced glutathione (GSH), there was an ATP‐dependent uptake of vincristine and daunorubicin, but not of APDA, into GLC 4/Adr and S1(MRP) membrane vesicles which could be inhibited by the MRP1‐inhibitor MK571. ATP‐ and GSH‐dependent transport of daunorubicin and vincristine into GLC 4/Adr membrane vesicles was inhibited by the MRP1‐specific monoclonal antibody QCRL‐3. MRP1‐mediated daunorubicin transport rates were dependent on the concentration of GSH and were maximal at concentrations 10 m M. The apparent KM value for GSH was 2.7 m M. Transport of daunorubicin in the presence of 10 m M GSH was inhibited by MK571 with an IC 50 of 0.4 μ M. In conclusion, these results demonstrate that MRP1 transports vincristine and daunorubicin in an ATP‐ and GSH‐dependent manner. APDA is not a substrate for MRP1. British Journal of Pharmacology (1999) 126, 681–688; doi:10.1038/sj.bjp.0702360
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · cited 3×
“MRP1 was first identified in tumour cells with a multidrug resistant phenotype without overexpression of MDR1.(2) Although MRP1 is able to confer resistance to drugs which are MDR1 substrates, the substrate specificity of MRP1 seems different from that of MDR1.”
BackgroundACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,784
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Tew, K. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3143 · Cited by 856
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 680
Müller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., & Jansen, P. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13033 · Cited by 617
Self-citationBindingDB (2013) · PubMed · doi:10.7270/q2q81fck · Cited by 571
Loe, D. W., Almquist, K. C., Deeley, R. G., & Cole, S. P. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9675 · Cited by 560
Zaman, G. J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F., & Borst, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7690 · Cited by 498
ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
Horio, M., Gottesman, M. M., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3580 · Cited by 476
P-glycoprotein—A mediator of multidrug resistance in tumour cells
Germann, U. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00057-3 · Cited by 405
Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer
Rogan, A. M., Hamilton, T. C., Young, R. C., Klecker, R. W., & Ozols, R. F. (1984) · Science · doi:10.1126/science.6372095 · Cited by 396
Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., & Beck, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1344 · Cited by 396
Biology of the multidrug resistance-associated protein, MRP
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00046-9 · Cited by 367
Urbatsch, I. L., Sankaran, B., Weber, J., & Senior, A. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19383 · Cited by 363
Rappa, G., Lorico, A., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 275
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
Jones, T. R., Zamboni, R., Belley, M., Champion, E., Charette, L., Ford-Hutchinson, A. W., Frenette, R., Gauthier, J.-Y., Leger, S., Masson, P., et al. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-004 · Cited by 270
ATP-dependent 17β-Estradiol 17-(β-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP)
Loe, D. W., Almquist, K. C., Cole, S. P. C., & Deeley, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9683 · Cited by 267
Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.
Zijlstra, J. G., de Vries, E. G. E., & Mulder, N. H. (1987) · PubMed · Cited by 265
Glutathione and related enzymes in multidrug resistance
O'Brien, M. L., & Tew, K. D. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00051-2 · Cited by 241
ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells.
Shapiro, A. B., & Ling, V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41923-5 · Cited by 230
Sharom, F. J., Yu, X., Chu, J. W. K., & Doige, C. A. (1995) · Biochemical Journal · doi:10.1042/bj3080381 · Cited by 217
Versantvoort, C., Broxterman, H., Bagrij, T., Scheper, R., & Twentyman, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.281 · Cited by 207
Loe, D. W., Stewart, R. K., Massey, T. E., Deeley, R. G., & Cole, S. P. C. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.1034 · Cited by 195
Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies.
Hipfner, D. R., Gauldie, S. D., Deeley, R. G., & Cole, S. P. C. (1994) · PubMed · Cited by 195
Tamai, I., & Safa, A. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46252-1 · Cited by 166
Gao, M., Loe, D. W., Grant, C. E., Cole, S. P. C., & Deeley, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27782 · Cited by 159
Roelofsen, H., Vos, T. A., Schippers, I. J., Kuipers, F., Koning, H., Moshage, H. J., Jansen, P. L. M., & Müller, M. M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024305 · Cited by 141
Self-citationFunctional expression of P-glycoproteins in secretory vesicles.
Ruetz, S., & Gros, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32712-6 · Cited by 131
Genetic dissection of the function of mammalian P-glycoproteins
Borst, P., & Schinkel, A. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01112-8 · Cited by 130
Taguchi, Y., Yoshida, A., Takada, Y., Komano, T., & Ueda, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01421-4 · Cited by 121
Physiology and Biochemistry of the Kidney Vacuolar H+-ATPase
Gluck, S. L., Underhill, D. M., Iyori, M., Holliday, L. S., Kostrominova, T. Y., & Lee, B. S. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.002235 · Cited by 119
Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger, H., Nooter, K., Gj, Z., Sonneveld, P., van Wingerden, K. E., Oostrum, R. G., & Stoter, G. (1994) · PubMed · Cited by 103
Barnouin, K., Leier, I., Jedlitschky, G., Pourtier, A., König, J., Lehmann, W., & KEPPLER, D. O. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.34 · Cited by 91
Multidrug resistance proteins and other drug transport-related resistance to natural product agents
Broxterman, H. J., Giaccone, G., & Lankelma, J. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199511000-00011 · Cited by 84
Müller, M. M., Roelofsen, H., & Jansen, P. L. M. (1996) · Seminars in Liver Disease · doi:10.1055/s-2007-1007233 · Cited by 75
Self-citationPriebe, W., Krawczyk, M., Kuo, M. T., YAMANE, Y., Savaraj, N., & Ishikawa, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8887 · Cited by 74
van Luyn, M. J. A., Müller, M., Renes, J., Meijer, C., Scheper, R. J., Nienhuis, E. F., Mulder, N. H., Jansen, P. L. M., & de Vries, E. G. E. (1998) · International Journal of Cancer · Cited by 62
Self-citationMüller, M. M., Mayer, R., Hero, U., & KEPPLER, D. O. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80312-9 · Cited by 56
Self-citationEfficient Purification and Reconstitution of P-glycoprotein for Functional and Structural Studies
Dong, M., Pénin, F., & Baggetto, L. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28875 · Cited by 54
Cited by
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
König, J., Nies, A. T., Cui, Y., Leier, I., & Keppler, D. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 791
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
“The transport of a number of unmodified drugs to which both MRP1 and MRP2 confer resistance, such as vincristine and doxorubicin, is dependent on or stimulated by GSH (85, 299, 301, 413).”
Background
Metadata
- Authors
- Renes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-02
- Volume
- 126
- Issue
- 3
- Pages
- 681-688
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2110319213
- Cited by
- 256
- References
- 46
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.